
NatWest, Tekcapital, and the FTSE 100 at 8,000 with Alan Green
UK Investor Magazine
00:00
The Impact of Driverless Technology on COPD Sufferers
The impact of this being used in snacks and fast foods is huge. So that Microsoft will be floating on name later on this year. Bellascare, the medical device company that's developed a portable oxygen concentrator for COPD sufferers,. tech capital owned 12% of Bellascura. And guidance announced an agreement with all of our technology using all of our technologies level four autonomous vehicles to bring an enhanced safety to self driving technology.
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.